Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Arch Development Corp. v. OSI Pharmaceuticals, LLC, No. 18-1485 (Fed. Cir. May 9, 2019)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 18-1485
Decided
May 9, 2019
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit

ARCH DEVELOPMENT CORPORATION, DANA-

FARBER CANCER INSTITUTE, INC.,

Appellants

v.

OSI PHARMACEUTICALS, LLC, GENENTECH,

INC.,

Appellees

UNITED STATES,

Intervenor

2018-1485

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2016-01034.

JUDGMENT

PETER A. SULLIVAN, Foley Hoag LLP, New York, NY, argued for appellants. Also represented by STEPHEN KENNY; DEANN FORAN SMITH, Boston, MA. BRIAN ROBERT MATSUI, Morrison & Foerster LLP,

2Washington, DC, argued for all appellees. Appellee Genentech, Inc. also represented by SETH W. LLOYD; MATTHEW A. CHIVVIS, MATTHEW IAN KREEGER, San Francisco, CA. THOMAS SAUNDERS, Wilmer Cutler Pickering Hale and Dorr LLP, Washington, DC, for appellee OSI Pharmaceuticals, LLC. Also represented by DAVID LANGDON CAVANAUGH, AMANDA L. MAJOR, HEATHER M. PETRUZZI, AMY K. WIGMORE; TIMOTHY ANDREW COOK, EMILY R. WHELAN, Boston, MA. KATHERINE TWOMEY ALLEN, Appellate Staff, Civil Division, United States Department of Justice, Washington, DC, argued for intervenor. Also represented by MARK R. FREEMAN, SCOTT R. MCINTOSH, JOSEPH H. HUNT; THOMAS W. KRAUSE, JOSEPH MATAL, FARHEENA YASMEEN RASHEED, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA.

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

BRYSON, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

May 9, 2019 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Arch Development Corp. v. OSI Pharmaceuticals, LLC, No. 18-1485 (Fed. Cir. May 9, 2019).

Record ID
CAFC-18-1485-20190509
Permalink
https://patentcasewatch.com/opinions/CAFC-18-1485-20190509

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.